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Abstract
Nanosized manganese oxide has excellent prospects. Some data imply that its 
particles can be toxic when introduced in various ways, and it requires further 
examination of this nanomaterial. The authors conducted research of nanodisperse 
MnO2 water suspension at intragastric, inhalation, and skin-resorptive introduc-
tion into small rodents and obtained profound characteristics of its toxic effects, 
determined target organs and revealed dose-dependent effects. The substance 
was characterized with acute toxicity, and its bioaccumulation under long-term 
exposure caused morphofunctional disorders in brain, lipid peroxidation activa-
tion, and lower antioxidant system activity. The authors detected vessel hyperemia, 
subarachnoid hemorrhages, brain edema with perivascular and pericellular spaces 
dilatation, nerve fiber demyelinization, and focal dystrophic changes in vessels 
endothelium. After a long-term introduction in doses from 0.25 to 2.5 mg/kg, 
oxidizing-antioxidant imbalance occurred, neurotransmitters and electrolytes 
balance was violated, and there was also brush border epithelium insufficiency. 
Nanodisperse MnO2 water suspension in doses equal to 2.5 and 0.25 mg/kg at 
intragastric introduction into Wistar rats did not have embryotoxic or teratogenic 
effects. It did not have any mutagenic effects in doses equal to 10.3 and 5.15 mg/kg 
or gonadotoxic effects either when introduced into Wistar male rats in doses equal 
to 10.3–5.15 mg/kg via gastric tube.
Keywords: nanodisperse magnesium oxide, toxicity, acute exposure, chronic 
exposure, long-term effects, inhalation and oral route
1. Introduction
Nowadays, one can see rapid growth in worldwide development and com-
mercialization of nanoindustries and nanotechnological products in overall 
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production chain; such products and technologies are considered to belong to 
a market segment of new technologies (the sixth technological structure) [1]. 
As per US Congressional Research Service experts assessment, world market of 
finished products and goods containing nanocomponents and nanomaterials now 
amounts to more than 1 trillion US dollars; it comprises more than 800 consumer 
goods produced with the use of nanotechnologies; by 2020, more than 15% of 
overall goods output in the world will be produced with the use of nanodevelop-
ments, and the volume of this market in various sectors will be equal to more 
than 3 trillion US dollars. Aggregate volume of investment into scientific research 
and start-ups related to nanotechnologies received from various sources world-
wide is estimated to amount to almost 20 billion US dollars. Annual nanoin-
dustries market growth is expected to reach 20–30% [2]. In experts’ opinion, 
nanoindustries and nanotechnologies (together with other technologies) are 
already facilitating transfer to new technological structure based on renewable 
energy sources, intellectual power engineering technologies, construction of 
completely new energy-efficient buildings, hydrogen technologies application, 
electrical and hybrid vehicle creation, 3D printer design and implementation, 
etc.
Nowadays, nanoclusters evolve quite intensely all over the world (more than 
1700 cluster organizations in 260 European regions) and in Russia (more than 330 
participating organizations). World market segments of nanomaterials develop as 
their commercial use in such key spheres as aerospace, health care, biotechnologies, 
power engineering, electronics and IT, processing industries, and consumer goods 
sector, grows rapidly [1, 3]. All this becomes apparent in the attitudes the European 
Union (EU) has toward the matter, declaring that nanotechnology is one of the Key 
Emerging Technologies 2020 Strategy. Its enormous potential for innovation has 
fostered large investments in developing new consumer products and industrial 
applications. The outlooks for a rapid growth in the sector have raised not only 
hopes and high expectations, but also societal concerns about the adequacy of 
nanotechnology regulation. Indeed, despite their clear benefits, engineered nano-
materials pose environmental and health risks [4].
All these processes prove the necessity to systematically examine potential 
dangers and threats for human activity, which are related to large-scale spread 
of nanotechnologies and nanobiotechnologies. In spite of all their undeniable 
innovative properties, nanomaterials including those containing metal nanopar-
ticles may cause certain health risk at all stages of production and product 
consumption due to their specific physical-chemical properties. They may also be 
dangerous for human environment objects and lead to grave social and economic 
consequences.
The challenges that researchers encountered provoked the need to develop 
reliable methods for characterization of nanoparticles released from various 
product matrices into complex biological, environmental and food media, and 
for the assessment of their human and environmental exposure, hazard, and risk 
[4]. Special attention is paid to detecting correlation between physical properties 
(i.e., size, shape, surface structure, and aggregation degree) of nanomaterials and 
toxic response induction in biological structures. This research direction has been 
actively developed in Federal Scientific Center for Medical and Preventive Health 
Risk Management Technologies (Perm) for many years. Physical properties of a 
number of widely spread metal-oxide nanoparticles as well as peculiarities of their 
biological and toxic effects exerted at various exposure types have not been studied 
sufficiently; so the research goal is to systemize the knowledge on the subject and to 
make it more precise.
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2.  Utilization prospects for nanosized particles of manganese oxide and 
sources of their introduction into environment
Nanosized particles of manganese oxide (МnO2) represent a prospective 
nanomaterial, which can be used for creating high-technology components 
applicable in nanoelectronics, nano-optics, and nanochemistry [5]. Nowadays, 
nanodisperse МnO2 is used as an active component in portable power sources, 
solar batteries, electrical appliances, accelerators, and sorbents [6, 7]. A possibil-
ity to use threadlike nanosized particles of МnO2 for sensor electrodes creation is 
of particular interest for researchers [7]. Planned production of matrices based 
on nanosized МnO2 for nanomagnetic materials and sorbents, nanoaccelerators, 
and semiconductor thermistors, can reach up to 1000 tons per year and is con-
sidered to be “mass production” [8]. Here, direct exposure of workers involved in 
the production process, as well as population living in areas influenced by such 
production, becomes quite possible. A possibility that the substance is introduced 
into the atmosphere in the form of aerosol is determined by technological pro-
cesses as nanoparticles of МnO2 are emitted in their course. Such processes include 
vacuum-ultrasound laser ablation applied in producing matrices of nanomagnetic 
materials and sorbents [9]. Laser ablation in suspension of nanodisperse МnO2 
includes local impulse-continuous heating of the substance, sublimation, crystal-
lization, and hydrodynamic processes, which cause formation of nanodisperse 
МnO2 aerosol.
Formation of nanodisperse МnO2 aerosol occurs in production of sensory 
electrodes, biosensors, [6], cathode accelerators, and semiconductor thermis-
tors [7], when electrochemical deposition is applied; this process means covering 
graphite rods with stable hydrosol of disperse МnO2 nanoparticles in electroplating 
baths. Sewage formed in the processes contains МnO2, and they can get into surface 
wells. Today, aerosol of nanodisperse МnO2 can be found in civil engineering and 
chemical production facilities. Working area air at a production facility manu-
facturing potash fertilizers was examined; the research results proved that МnO2 
particles were present in the air; thus, there were about 4435–7330 million/m3 
particles sized 45–95 nm at a carrier driver workplace in a milling workshop (МnO2 
content in working area air was equal to 0.3 mg/m3). Nanoparticles sized 5–25 nm 
in concentrations equal to 4588–11,423 million/m3 were registered at a machine 
operator workplace in a granulating workshop. Manganese particles were identified 
among those nanoparticles via mass-spectrometry technique with inductive-bound 
plasma; Agilent 7500cx mass-spectrometer with octopole reaction collision cell 
was applied (Agilent Technologies Inc., USA) [10]. There are some data implying 
that МnO2 particles can be toxic when introduced in various ways, and it requires 
further examination of this nanomaterial.
Detailed research on nanosized particles toxicity involves a wide range of tasks 
according to the recommendations set forth by Good laboratory practice (GLP): 
toxicology evaluation, single dose, repeated dose, toxicokinetics, genotoxicity, 
reproductive and developmental toxicology, and local toxicity. According to these 
recommendations, the authors have assessed toxicity of nanosized МnO2. All the 
animals before the experiment underwent 14-day quarantine and were placed in 
standard cages made of polypropylene, two animals in each. Cages were in a venti-
lated room. Air temperature in the room was constant and equal to 23.0 ± 2.0°C, and 
air humidity was 60.0 ± 5.0%. The animals received semisynthetic nutrition with 
food and biological value, which completely satisfied all physiological needs. They 
also had free access to food and water. All procedures and examinations on animals 
were performed in full conformity with guide for the care and use of laboratory 
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animals (ILAR, DELS) [11] and requirements set forth by Ethics Committee of 
Federal Scientific Center for Medical and Preventive Health Risk Management 
Technologies.
3. Results and discussion
3.1 Physical and chemical properties of nanodisperse magnesium oxide
The following substances were tested during the experiment: water suspen-
sion of nanodisperse magnesium oxide (III, IV) (manganese (III, IV) oxide, CAS 
Registry Number 1313-13-09). IUPAC name: manganese oxide and manganese (III, 
IV) oxide. Synonyms: manganese dioxide, manganese binoxide, and manganese 
peroxide [12].
According to the results of studying the particle size and shape with inde-
pendent methods, it is found that the МnO2 sample tested was a nanomaterial. 
This is evidenced by the study results of the water suspension test sample (МnO2 
concentration is 36.0 ± 2.3 mg/cm3) with a residual CTAB in the suspension below 
the detection threshold (0.00001 mg/cm3). The particle size distribution (cross-
sectional dimension determined with dynamic laser light scattering) is represented 
in the bar chart as follows: 13 nm (1.2% of the total number of particles), 15–29 nm 
(94.4% of the total number of particles), and 33–100 nm (4.1% of the total number 
of particles). The maximum peak value of the particle size made 19 ± 4 nm (41.2% 
of the total number of particles) (Table 1).
Scanning electron microscopy revealed that the particles being visualized 
exceeded 20 nm in size. The difference with the previous method may be due to a 
failed focus of the scanning microscope on the nanoparticles smaller than 20 nm, 
despite sensitivity of 3–10 nm, as stated in its data sheet. As seen in particles are of 
filamentary shape (97.8% of the total number of particles). The determined sizes 
and the shape of particles are confirmed by atomic force microscopy (Figures 1 
and 2).
The textural characteristics of resulting material studied showed that the 
adsorption-desorption isotherm of nitrogen corresponds to the type IV (isotherm 
with a distinct capillary condensation), and the shape of the hysteresis loop belongs 
to H3 type with the distinct area of mesopores filling within the range of relative 
pressures (p/p0) 0.7–1. In other words, mesopores filling at higher relative pressures 
verifies the presence of large diameter mesopores (Figure 3).
The maximum pore size distribution occurs in the range of ~10 nm. The specific 
surface area (SBET) of the nanosized particles, calculated by Brunauer et al. [17], 
amounted to 150.2 ± 2.6 m2/g. The total pore volume was equal to 0.676 cm3/g (the 
total pores volume (Vtot) was calculated from the amount of nitrogen adsorbed at a 
relative pressure p/p0 ≈ 0.99. Pore size distribution was determined by the desorp-
tion isotherms by Barrett et al. [16]).
The water suspension of nanodisperse magnesium oxide had the following 
physicochemical characteristics: сhemical formula: MnO2, smiles: О═Mn═O, molar 
mass: 6.9368 g/mol, chemical composition of the nanosized phase: metal, presence 
of solvent: matrix-bidistilled water, particle charge: neutral at рН = 7.4, resistance 
to aggregation: particles are prone to aggregation, hydrophobicity: hydrophilic 
substance, Bp at 76 mm Hg: 3127°C, Bm: 1080°C; vapor tension (mm Hg) and 
volatility (mg/m3 20°C): undetermined, specific weight: 4.8 g/cm3, water solubility: 
insoluble, oil/water ratio: undetermined, and aggregation state: in water at 20 and 
35°C—dark brown solid substance, in air at 20 and 35°C—dark brown powder, of 
high strength and hardness.
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3.2  Acute toxicity study of nanodisperse manganese oxide at various types of 
introduction into a body
3.2.1 Acute toxicity study of MnO2 nanoparticles under inhalation exposure
Over the last decade, a lot of researchers have dedicated their work to practical 
application of a priority nanomaterial, namely, nanodisperse МnO2 [15]. They are 
particularly interested in examining possibilities to use threadlike nanosized МnO2 
particles for sensory electrodes creation [6, 7] or cathode accelerator creation [7] at 
Size of particles in a suspension, micron Proportion of particles, %
0.0131 1.2
0.0150 9.6
0.0171 16.4
0.0196 20.0
0.0225 21.2
0.0257 13.9
0.0295 13.2
0.0338 0.44
0.0387 0.38
0.0443 0.64
0.0507 0.90
0.0581 0.73
0.0666 0.42
0.0762 0.39
0.0873 0.15
Table 1. 
Distribution of MnO2 nanoparticles in a water suspension versus particle size using dynamic light scattering 
analyzer Horiba LB-550 (Horiba, Japan) [16].
Figure 1. 
Scanning electron microscopy image of MnO2 nanoparticles, electron microscopy with a high-resolution 
scanning microscope (3–10 nm, max magnification of 300,000X) S-3400 N (Hitachi, Japan) with energy 
dispersive X-ray attachment for microanalysis (Bruker, Germany) [18].
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covering graphite rods via electrochemical deposition, up-to-date sorbents with the 
use of vacuum-ultrasound laser ablation [13, 14]. Inhalation exposure of workers to 
nanosized МnO2 particles is quite possible during such manufacturing processes as 
these particles are emitted into working area air. In relation to that, wider utilization 
of nanosized МnO2 in industrial production as well as providing workers’ safety in 
the process requires more profound studies on toxicity of nanodisperse МnO2 when 
it enters a body being inhaled as an aerosol.
The authors used water suspension of nanodisperse MnO2 in concentration 
equal to 36.0 ± 2.3 mg/cm3 as an examined substance. To make comparison, 
microdisperse MnO2 with concentration in manganese water suspension equal to 
40.31 ± 1.6 mg/cm3 was used. The particles size amounted to 5.5–37.0 μm (particles’ 
share 67.0%). The size of microdisperse MnO2 particles is 194–1300 times greater 
than the nanodisperse MnO2 particles size. Specific surface area of MnO2 nanopar-
ticles (Brunauer-Emmett-Teller technique [17]) was equal to 150.23 m2/g, which was 
1.2 times higher than microparticle-specific surface area (130 m2/g). This property 
can cause high MnO2 nanoparticles reactivity in vitro and in vivo [19].
To determine acute toxicity parameters, the authors completed an experiment 
on pubescent Wistar rats (male and female) with body weight equal to 190 ± 10 g. 
They examined and assessed acute toxicity of nanodisperse MnO2 water suspen-
sion at inhalation introduction as an aerosol in accordance with Interstate Standard 
“Testing techniques on determining chemical products effects exerted on a human 
body: acute inhalation toxicity technique determining acute toxicity class (ATC 
Figure 3. 
Nanodisperse MnO2: (a) nitrogen isotherm adsorption-desorption and (b) pore size distribution d (nm) [18].
Figure 2. 
The 3D-pattern of the MnO2 nanodisperse particles, atomic force microscopy with the use of solver-PRO 
microscope (NT-MDT, Russian) [10].
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technique)” (OECD, Test No 436:2008, IDT) (2012). Inhalation introduction into 
the experimental animals’ bodies was modeled in inhalation system with integrated 
software; and a chamber for a whole body was used in the process (TSE Systems 
GmbH, Germany). The experimental animals were divided into three groups 
(experimental groups were 1 and 2, and group 3 was a control one, n = 18 animals). 
Experimental group 1 was exposed to the examined substance inhalation at sub-
stance nominal concentration in the chamber equal to 0.05 mg/l; concentration for 
experimental group 2 was equal to 0.5 mg/l. The exposure lasted for 4 hours; the 
animals received no nutrition during the process. After inhalation exposure, the 
animals were observed during next 96 hours to detect possible delayed substance 
toxicity. Control group was exposed to inhalation of distilled water in the form of an 
aerosol under analogous conditions. The water conformed to TU 6-09-2502-77. After 
observation period for the animals from experimental groups 1 and 2 was over, they 
were taken out of the experiment via sparing euthanasia. Brains were extracted with 
a special instrument and fixed in 5% solution of buffered neutral formalin. Fixed tis-
sue pieces were dehydrated in Excelsior ES automatic histological processor (Thermo 
Scientific, Germany). The finished specimens were examined in Axio Lab A1 light-
optical microscope, micropictures were taken with the use of Mikroskopkamera 
AxioCam ERc 5 s (Carl Zeiss, Germany) at magnification equal to ×400.
The results of all research performed with independent techniques application 
helped to detect that the examined MnO2 sample was a nanomaterial. The examina-
tion of the tested substance suspension in concentration equal to 36.0 ± 2.3 mg/cm3 
proves it. Particle size distribution on the bar graph is as follows (particles cross-
section size is presented): 13 nm (1.2% of the total particles number), 15–29 nm 
(94.4%), and 33–100 nm (4.1%). Maximum peak of particles size corresponded to 
19 ± 4 nm (41.2%). Scanning electron microscopy technique enabled detecting that 
visualized particles size exceeded 20 nm. Assessment of nanoparticles quantity in 
the inhalation chamber area showed that when nanodisperse fraction is fed into the 
chamber and transfers into aerosol, it does not agglomerate to micrometer range 
(Figures 4 and 5). The size of most particles (99% from the total quantity) does not 
exceed 100 nm at the examined actual concentrations after 2–4 hours of exposure.
Clinical picture of acute intoxication at inhalation exposure to nanodisperse 
MnO2 aerosol at actual concentration equal to 0.029 ± 0.001 mg/dm
3 was character-
ized with evident neurotoxic effects, which started to occur in male and female 
rats from experimental group 1 after 3 hours of exposure. Animals had movement 
coordination disorders, took unusual postures, and showed weaker reaction to 
sound stimulus; all these effects remained in survivor animals during 48 hours 
after exposure. When actual concentration was equal to 0.472 ± 0.005 mg/dm3, rats 
started to suffer from apparent respiratory failure after 30 minutes of exposure.
Most rats in experimental group 2 (three male and two female) died within 
150–190 minutes after the experiment started; their death was caused by acute 
respiratory failure. One female rat died 2 hours after the experiment was over. The 
animals were sluggish before their death, they took lateral position, and demon-
strated no reaction to sound stimulus or motion activity. Death of the experimental 
animals was not established. CL50 of the examined nanodisperse MnO2 amounted to 
0.12 mg/l. This concentration is within 0.05–0.5 mg/l range, which allows to define 
the tested substance as having the second hazard class “ATC technique” (OECD, 
Test No. 436:2008, IDT). It is known that minimal toxic concentration (TCL0) of 
nanosized МnO2 for rats at inhalation introduction during 24 hours amounts to 
1.8 mg/m3; for mice during 7 hours, 49 mg/m3 (data taken from Minimal lethal 
dose (LDL0) for rats at intratracheal introduction amount to 45 mg/kg. Safety 
specification does not contain any additional information regarding errors, confi-
dence limits, or animals sex. Morphologic changes in brain tissues of the rats from 
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experimental group 1 in comparison with control group were characterized with 
the following pathologic disorders: brain substance vessels were filled with blood 
insignificantly or moderately and had focal endothelium swelling and perivascu-
lar spaces dilatation. The most apparent changes in brain tissue of the rats from 
experimental group 1 occurred in cerebellum. Neurons and neuroglia cells were 
characterized with grave ischemic damages in the form of wrinkling and pyknosis. 
Nerve fibers of brain tissue looked spongy and were unevenly colored, had fizzy 
contours, and focal prolapse of glial elements (Figure 6).
Figure 4. 
Nanoparticle concentration in the inhalation chamber air at actual MnO2 concentration equal to 
0.029 ± 0.001 mg/dm3 [18].
Figure 5. 
Nanoparticle concentration in the inhalation chamber air at actual MnO2 concentration equal to 
0.472 ± 0.005 mg/dm3 [18].
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The results obtained in the course of the research indicate that the examined 
nanosized МnO2 particles can cause neurotoxic effect and respiratory failure; the 
combination of these two factors could lead to the animals’ death. The obtained 
results are confirmed by research performed by a number of authors [20, 21], 
which prove that МnO2 nanoparticles exert toxic effects at inhalation exposure. 
Thus, after 24-hour exposure, catalytic generation of active oxygen forms (AOF) in 
human alveolar epithelial cells [20] increased; level of extracellular and intracellular 
oxidized glutathione form (GSSG) also grew by 30 and 80% correspondingly [20, 
21]. Manganese oxide (IV) nanoparticles sized up to 30 nm are able to penetrate 
into neuron-like PC-12 cells of a brain at inhalation exposure via olfactory nerve 
[22] and accumulate in astrocytes [13, 23].
Here, slight mitochondrial activity inhibition occurs; dose-dependent decrease 
in dopamine and its metabolites (3,4-dihydroxyphenylacetic acid and homovanillic 
acid) takes place. This process is accompanied with a multiple AOF growth [20, 
24] and becomes apparent in experimental animals through neurodegenerating 
disorders as early as after 2 or 3 weeks of exposure [20, 23, 24]. It is proved that 
МnO2 nanoparticles (III, IV) can accumulate in brain cells [25, 26]. In particular, 
astrocytes are able to accumulate МnO2 nanoparticles and produce AOF [25, 27, 28]. 
This process is accompanied with protein cleavage activation mediated by caspase-3 
and protein kinase Сδ (these are enzymes that participate in apoptosis, necrosis, 
and inflammatory processes), as well as phosphorylation cycle activation [25, 26]. 
As particles concentration increases, level of p38 mutagen-active protein kinase 
grows linearly; this protein kinase activates apoptotic mechanism of untimely cell 
death [24, 29–31]. Tumor necrosis factor-α doubles in olfactory bulb, frontal cortex, 
midbrain, and striate body [27]. If inhalation exposure to МnO2 nanoparticles (III, 
IV) is long-term, time-depending activation of transferrin in dopaminergic nervous 
cells is detected, as well as structural changes in Beclin 1 and LC3 proteins, which, 
in its turn, can be an evidence of potential autophagia process activation [20].
As per data taken from the annotated scientific literature, it is proved that 
toxic effects exerted on nervous system cells can be caused both by nanoparticles 
[25, 29] and by microdisperse analog at a low-dose exposure [32]. Disorders in 
neurons membranes functions can underlie the neurotoxic action mechanism; 
such disorders result from membranes lipid peroxidation which in its turn is 
caused by direct cytotoxic effect of nanoparticles determined for dopaminergic 
Figure 6. 
Cerebellum of a Wistar rat after acute inhalation exposure to nanodisperse MnO2 aerosol at actual MnO2 
concentration in the inhalation chamber area equal to 0.029 ± 0.001 mg/dm3 (painted with hematoxylin-eosin, 
×400): А is cerebellum tissue without changes, green; B is ischemia focus (grave ischemic changes), edema 
(damage zone is outlined); С is motor neuron of cerebellum subcortex; and D is glia cells with pericellular 
space dilatation [18].
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neurons [25, 29, 33]. This effect can be more apparent for nanodisperse particles 
in comparison with microdisperse analog effects due to the fact that nanopar-
ticles have a greater specific surface area.
Mechanism of nanodisperse MnO2 neurotoxicity is related to the ability to 
generate free radicals and to interact with proteins. Manganese oxide nanoparticles 
are able to actively generate free radicals when they interact with bilipid layer of 
cell membranes [25, 30]. When interacting with cell membranes, they stimulate 
excessive creation of active oxygen forms (AOF), which is accompanied with high 
catalytic activity and cell apoptosis [25, 26, 30]. Oxidized (GSSG) and reduced 
glutathione form (GSH) content is one of the parameters showing oxidative stress 
level. It is proved that if alveolar epithelial cells are exposed to МnO2 particles 
for 24 hours, the level of extracellular and intracellular GSSG increases by 30 
and 80% correspondingly; at the same time, caspase-3 activity grows and this 
enzyme is known to induce apoptosis processes. GSH concentration increases 
after 24-hour exposure to the examined substance, and it can be caused by activa-
tion of γ-glutamylcysteine synthetase synthesis and more active feed system of 
cystine and glutamate amino acids, which are substrates for synthesis of reduced 
glutathione form [25]. A significant increase in GSSG in a cell induced by МnO2 
nanoparticles can be caused by manganese particles entering reduction reaction 
with superoxide formation, which, under superoxide dismutase effects, is con-
verted into oxygen and hydrogen peroxide. Then, hydrogen peroxide decomposes 
with the help of reduced glutathione form, and it leads to GSSG increase. Another 
possible way of hydrogen peroxide transformation in a cell is hydroxyl radicals 
creation in the presence of manganese ions; these radicals are also able to oxidize 
GSH with creation of GSSG [26].
Clinical picture of acute intoxication, detailed in the previous works by the 
authors [34], confirms the mechanism of toxic effects exerted by nanodisperse 
MnO2 particles which a number of authors describe in above-mentioned scientific 
works [27, 28]. Respiratory failure evolvement can also be related to potential ability 
of the examined nanoparticles to cause inflammatory changes with consequent 
apoptosis of alveolar epithelial cells. At the same time, МnO2 nanoparticles have 
greater resistance to mucociliary clearance; therefore, they are in a longer contact 
with respiratory tract cells in comparison with microdisperse analog [28].
3.2.2  Examination of acute toxicity which nanodisperse MnO2 has at oral 
introduction
Intensive development of the major promising nanotechnological spheres such 
as nano-optics, nanoelectronics, pharmacology, chemistry, and metallurgy has 
direct influence on growth of nanodisperse MnO2 production volumes. Nanosized 
MnO2 particles are widely used in production of matrixes for nanomagnetic materi-
als and sorbents [35], nanoaccelerators, semiconductor thermistors [36]. Wastes 
of such productions can get into sewage and then into water reservoirs serving as 
sources for drinking water supply. MnO2 nanoparticles are known to have nons-
pherical form, which makes for lower speed of their excretion out of a body with 
the help of immune system’s phagocytes through lymphatic ducts and causes their 
longer contacts with body tissues [19]. In relation to that it is reasonable to think 
that profound examination of nanodisperse МnO2 aerosol toxicity at oral introduc-
tion with water into a body is of great importance for securing production workers 
safety and safety of population living in areas influenced by such productions.
The authors examined nanodisperse MnO2 water suspension with particles sized 
15–29 nm. Particles were thread-like and had surface area equal to 150.2 ± 2.6 m2/g. 
MnO2 concentration in nanodisperse solution was equal to 36.0 ± 2.3 mg/cm
3. 
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The detailed description of synthesis and physical and chemical properties of 
nanodisperse MnO2 is given in the precious works [37, 38]. To make comparison, 
microdisperse MnO2 with concentration in manganese water suspension equal to 
40.31 ± 1.6 mg/cm3 was used. The particle size amounted to 5.5–37.0 μm (particles’ 
share 67.0%) (dynamic light scattering technique with the use of Microtrac S3500 
laser analyzer (Microtrac, the USA)). The size of microdisperse MnO2 particles is 
194–1300 times greater than nanodisperse MnO2 particle size. Specific surface area 
of MnO2 nanoparticles (Brunauer–Emmett–Teller technique [17]) was equal to 
150.23 m2/g, which was 1.2 times higher than microparticles specific surface area 
(130 m2/g). Acute toxicity parameters of nanodisperse MnO2 were assessed as per the 
results of comprehensive acute experiments performed in accordance with methodi-
cal guidelines [10] on nonlinear male white mice with body weight equal to 27 ± 2 г 
(M ± m) (n = 70); the animals belonged to a conventional category. Nanodisperse 
MnO2 was introduced into mice’s bodies a single time via gastric tube in various 
doses: group 1 received 2000 mg/kg of body weight, group 2–3500 mg/kg, and 
group 3–5000 mg/kg. The tested sample was introduced in a form of water suspen-
sion in volume equal to 1–2% of the animals’ body weight. Microdisperse MnO2 was 
introduced into mice from experimental groups 4, 5, and 6 in the same doses as in 
groups 1, 2, and 3. The tested samples were introduced in the same way. Control 
group 7 received water a single time via gastric tube in the same volume. The observa-
tion term after the tested substances was introduced amounted to 14 days. Mice were 
kept in cages: five animals in each.
The experiment revealed that clinical picture of acute intoxication at introduc-
ing nano- and microdisperse MnO2 solutions is uniform and nonspecific. Animals 
from experimental groups 1–6 suffered from hyperexcitability and convulsions 
during the first 20 minutes of the experiment; then inhibition state occurred, 
animals’ reaction to sound and pain became weak, they had hypopnoe. Animals 
in experimental groups 2 and 3 died mostly during the first 24 hours; in group 1, 
during 48 hours; and in comparison groups 5 and 6 in the period from 48 to 
72 hours. No mice from group 4 or 7 died in the course of the experiment. It was 
detected that if nanodisperse MnO2 solution was once introduced into a body via 
gastric tube, LD50 amounted to 2340 ± 602.6 mg/kg of body weight (third hazard 
class); in case of microdisperse MnO2 solution introduction, the dose was equal to 
6000 ± 485.6 mg/kg (fourth hazard class). Average death time (TL50) for mice after 
intragastric introduction of nanodisperse MnO2 solution amounted to 35.2 hours. 
When microdisperse MnO2 solution was introduced, TL50 amounted to 32 hours. 
Cumulation index amounted to 0.79 for nanodisperse MnO2 particles. If cumulation 
index is >5, one can assume that nanoparticles are hypercumulative. Cumulation 
index is equal to 0 for microdisperse MnO2 particles. If cumulation index is equal to 
0, one can assume that particles are moderately cumulative [39].
Analysis of changes, which occurred in venous blood of the experimental 
animals, revealed that nanoparticles of disperse MnO2 solution in a dose equal 
to 3500 and 5000 mg/kg exert more apparent toxic effects on erythrocytes and 
thrombocytes in comparison with a microdisperse analog. It is confirmed by 
polychromatocytes occurrence as their share amounted to 20 and 35% of the total 
erythrocytes number in peripheral blood of mice from experimental groups 2 and 
3 correspondingly. When microdisperse MnO2 was introduced in the same doses 
polychromatocytes share in mice’s blood amounted to 10 and 15% correspondingly. 
10–20% of erythrocytes in blood of mice from those groups contained pathologic 
Jolly bodies and it was two times higher than the same parameter in blood of mice 
from experimental groups 5 and 6 correspondingly. Nanodisperse MnO2 solution 
caused massive thrombocytes aggregation in blood of mice from experimental 
groups 2 and 3. Microdisperse MnO2 solution when introduced into mice in a dose 
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equal to 5000 mg/kg (experimental group 6) led to only sporadic occurrence of 
thrombocytes aggregation. There were no pathologic changes in blood slides of mice 
from experimental group 7.
Morphological examinations after introducing nanodisperse MnO2 solution in 
a dose equal to 3500 mg/kg revealed changes in all examined organs taken out of 
mice. There was significant dilatation and hyperemia of veins in liver and kidneys, 
considerable blood overflow in veins of cardiac muscle and epicardium, as well 
as in heart chambers. There were hemorrhages detected in medullar substance of 
kidneys. Proliferative processes occurred in macrophage and lymphoid systems of 
experimental animals. An increased number of macrophages and their activation 
was detected in liver, in both kidneys and, in particular, in lungs (Figure 7). Kupffer 
cells in liver are enlarged and bulged into sinusoid capillaries lumen; mesangial 
cells in renal bodies are hypertrophic, and numerous alveolar macrophages contain 
phagocyte material. Lymphoid nodules in spleen white pulp are enlarged, tend to 
fuse, and there is no typical division into zones in them. Red pulp prevails in the 
organ together with diffuse and focal lymphatization occurrence. Proliferation 
of cells from lymphocytes and macrophages range leads to leukocytic infiltration 
of parenchymatous organs. Numerous periportal and intralobular lymphoid-
histiocytic infiltrates occur in liver; perivascular and intertubular ones are observed 
in kidneys. Organ infiltration with lymphocytes is so active that it can penetrate 
through blood-brain barrier; lymphoid infiltrates can be detected even in white 
substance of cerebral hemispheres (Figures 8-10).
When a microdisperse MnO2 solution in a dose equal to 3500 mg/kg was 
introduced, it led to some dilatation of sinusoid capillaries in liver and vessels of 
renal microcirculatory bed. Capsule lumen in some renal corpuscles was dilated. 
Occasional lymph-histiocytic infiltration occurred in parenchymatous organs. 
Infiltrates were located only in connective tissue and were rather small. As opposed 
to group 2, animals from group 5 had no infiltrates in brain hemispheres cortex. 
There was only slight perivascular and moderate pericellular edema located mostly 
in granular layer.
Therefore, mice from group 2 after a single introduction of nanodisperse MnO2 
solution in a dose equal to 3500 mg/kg via gastric tube had more apparent morpho-
logical changes in internal organs than mice from group 5 (microdisperse analog). 
These changes were detected in circulatory system and characterized with dilatation 
and hyperemia of veins in all the studied organs. Blood overflow in veins of cardiac 
Figure 7. 
Macrophage reaction in a lung of a mouse from experimental group 2, which died during the first day 
after nanodisperse MnO2 in a dose equal to 3500 mg/kg, was introduced. The specimen was painted with 
hematoxylin and eosin, and the magnification was equal to ×1000 [38].
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Figure 8. 
A nonlinear mouse from experimental group 2, which died during the first day after nanodisperse MnO2 in a 
dose equal to 3500 mg/kg, was introduced. Lymph-histiocytic intralobular infiltrates in a liver. The specimen is 
painted with hematoxylin and eosin, and magnification is equal to ×200 [38].
Figure 9. 
A nonlinear mouse from experimental group 2, which died during the first day after nanodisperse MnO2 in a 
dose equal to 3500 mg/kg, was introduced. Lymph-histiocytic perivascular infiltrates in a kidney. The specimen 
is painted with hematoxylin and eosin, and magnification is equal to ×200 [38].
Figure 10. 
A nonlinear mouse from experimental group 2, which died during the first day after nanodisperse MnO2 
in a dose equal to 3500 mg/kg, was introduced. The specimen is painted with hematoxylin and eosin, and 
magnification is equal to ×400. Lymphocytic infiltration in white substance of cerebral hemispheres [38].
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muscle, epicardium and all heart chambers was particularly evident. Mice from 
group 5 had no peculiar morphological changes in circulatory system organs. Mice 
from group 2 had proliferative processes in lymphoid and macrophage systems. 
These processes were morphologically apparent through hypertrophy of thymus 
lobules cortex, lymphoid follicles of spleen white pulp and lymphatization of spleen 
red pulp, and macrophage activation in liver, kidneys and lungs. Such morphologi-
cal changes did not occur in mice from group 5. Proliferation of lymphoid cells and 
macrophages leads to histioleukocytic infiltration of parenchymatous organs. And 
here, processes caused by nanodisperse MnO2 solution impact are more apparent 
than those caused by microdisperse MnO2 solution. Morphological changes are 
determined by vascular disorders in venous bed, which result in hemorrhages in 
parenchymatous organs, especially in kidneys. There were none of such morpho-
logical changes in mice when microdisperse MnO2 solution was introduced into 
them. The analysis of the obtained results allows to make a conclusion that nano-
disperse MnO2 solution at a single introduction via gastric tube has LD50 equal to 
2340 ± 602.6 mg/kg (third hazard class), which is 2.6 times higher than LD50 equal 
to 6000 ± 485.6 mg/kg at a single introduction of microdisperse MnO2 solution 
(fourth hazard class). Nanodisperse MnO2 solution at single introduction into 
mice via gastric tube in a dose equal to 3500 mg/kg exerts hemotoxic effects, which 
reveal themselves in a form of pathologic inclusions in erythrocytes and increased 
thrombocytes aggregation. There were also certain circulation disorders observed 
such as vein dilatation and hyperemia, as well as filling of their lumen with erythro-
cytes, which leads to hemorrhages in all the studied organs. Proliferative processes 
in lymphoid and macrophage systems were detected; they result in hypertrophy of 
thymus lobule cortex and lymphoid follicles of spleen white pulp, lymphatization of 
spleen red pulp, and macrophages activation in liver, kidneys and lungs.
3.3  Studying subchronic and chronic toxicity of nanodisperse manganese oxide 
water suspension at intragastric introduction via gastric tube
Studying subchronic toxicity of nanodisperse МnO2 water suspension at 
intragastric introduction via gastric tube: nowadays, there is a growing interest 
in using МnO2 nanoparticles as a sorbent and catalyst for complex purification 
of liquid radioactive wastes, which are dangerous for human health. But МnO2 
nanoparticles can get into sewage in the process and later they can be found in 
surface water reservoirs used for drinking water supply to population. In relation to 
that, study of toxic effects exerted by МnO2 nanoparticles at oral introduction with 
drinking water matters a lot if one wants to assess their safety.
Experimental research dedicated to nanodisperse MnO2 were performed with 
intragastric introduction via gastric tube during 90 days. During this particular 
research, nanodisperse MnO2 water suspension was introduced into Wistar rats 
(males and females) with body weight equal to 200 ± 10 g (n = 100) via gastric tube 
daily for 90 days. Animals were divided into four experimental groups and 1 control 
group, 20 animals in each. Nanodisperse MnO2 water suspension was introduced in 
the following doses: group 1—257.7 mg/kg (1/10 LD50), group 2—51.54 mg/kg (1/50 
LD50), group 3—10.3 mg/kg (1/250 LD50
3), group 4—5.15 mg/kg (1/500 LD50), and 
group 5 (control one)—distilled water in volume equal. Nanodisperse MnO2 water 
suspension dispersion was accomplished directly before carrying out the research 
and later on a weekly basis during 90 days, while the experiment was lasting in 
order to achieve even particles distribution in a volume of liquid; the procedure was 
done with the use of ultrasound at room temperature under continuous pulsation 
at 65%-power for 2 minutes. The following parameters were assessed: body weight 
dynamics, as well as changes in biochemical parameters of neurons functions and 
15
Toxicologic Characteristics of Nanodisperse Manganese Oxide: Physical-Chemical Properties…
DOI: http://dx.doi.org/10.5772/intechopen.83499
oxidation-antioxidant system balance. Morphological changes in brain tissues were 
studied via histological specimens microscopy (magnification ×400).
Body weight dynamics analysis performed on rats from group 1 revealed 
authentic decrease in this parameter by 7.7% by the 30th day of the experiment in 
comparison with the baseline. Body weight was recovered by the 90th day. Decrease 
in body weight of rats from group 1 authentically differed from this parameter in 
control group during the whole experiment. In all other groups, authentic increase 
in body weight of experimental animals was detected. Examination and assessment 
of biochemical parameters characterizing neurotransmitters balance and oxidation-
antioxidant system at long-term introduction of nanodisperse MnO2 water suspen-
sion proves negative effects occurrence; these effects are dose depending. There 
was an authentic increase in lipid hydroperoxide level in blood serum of rats on 
the 30th day of the experiment when doses were 10.0–260 mg/kg of body weight; 
this parameter was 1.4–1.9 times higher than the baseline in rats from the control 
group (р < 0.001). Malonic dialdehyde level in blood serum of rats was 1.6–2.0 
times higher than the baseline of this parameter in control group rats, the doses 
being equal (р < 0.001). On the 90th day, high levels of lipids hydroperoxides and 
malonic dialdehyde in blood serum remained. The order of discrepancy between 
the baseline and parameters in the control group was 1.3–1.9 times (р < 0.001). 
When a dose was equal to 5.0 mg/kg, there were not any authentic discrepancies 
between these parameters and the baseline, or between them and control group 
parameters during the whole experiment. When doses were 10.0–260 mg/kg, an 
authentic decrease in Cu/Zn-SOD and OAS in blood serum of rats was registered; 
this decrease was dose dependent. During the whole experiment, Cu/Zn-SOD level 
was on average from 1.4 to 4.6 times lower than the baseline and the control group 
parameter (р < 0.001–0.002). OAS level was 1.6–5.4 times lower (р < 0.001). When 
a dose was equal to 5.0 mg/kg, there were no authentic discrepancies in OAS level 
between experimental and control group during the whole experiment.
Assessment of basic neurotransmitters content in blood serum of rats on the 
90th day of the experiment revealed authentic increase in glutamate level and 
decrease in GABA level in comparison with the baseline and control group. Changes 
in these parameters were dose dependent. Glutamate level in blood serum grew 
from 2 to 3.8 times depending on a dose (р < 0.001). GABA level in blood serum 
decreased 2.3–2.7 times (р < 0.001). When a dose was equal to 5.0 mg/kg, there was 
no authentic decrease in the analyzed parameters in blood serum against control 
group parameters. The obtained results show that, given their small size and high 
penetrability, МnO2 nanoparticles can penetrate through blood-brain barrier and 
cause morphological-functional disorders in various sections of central nervous 
system when introduced into a body in different ways even in relatively small 
concentrations [27].
The detected activation of cell membranes lipid peroxidation and imbalance in 
CNS neuromediators at intragastric introduction of nanodispersed MnO2, in Wistar 
rats, are confirmed by the results obtained by a number of authors at other ways of 
introduction into a body (for example, at intranasal, intratracheal, and inhalation 
introduction). As a number of authors state, when МnO2 particle dose equals to 
2.63 mg/kg and intranasal introduction of this dose lasts for 6 weeks, neurotoxicity 
can be observed as relative refractory period of a tail nerve grows [27]. Intratracheal 
introduction of МnO2 nanoparticles in a dose equal to 2.63 mg/kg during 6 weeks 
leads to significant decrease in body weight, longer absolute refractory period of a 
tail nerve, and lower animals movability [27]. Neurotoxicity of МnO2 nanoparticles 
at intratracheal introduction in doses equal to 2.63 and 5.26 mg/kg can be seen 
through increase in latent period of cortical potential occurrence (total response 
of large cortex neurons populations to synchronous impulses flow coming to them 
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and caused by afferent irritator) in visual, auditory, and the first somatosensory 
area. This effect can be determined by disorders in neuron membranes functions 
as a result of membrane lipid peroxidation accompanied with calcium homeostasis 
disorders [23]. Nanoparticles and microparticles of МnO2 in concentration equal 
to 100 μg/kg in saline were injected into rats once a 2 weeks during 14 weeks, and 
it allowed to determine that both substances caused authentic increase in dextrose 
and cholesterol level. МnO2 nanoparticles lowered the level of high-density lipopro-
teins at the sixth, twelfth, and fourteenth week, while microdisperse analog caused 
such decrease at the twelfth week only. Researchers detected no authentic changes 
in triglyceride concentration. Changes in biochemical profile might be caused by 
oxidizing possibilities, which МnO2 nanoparticles have [40]. An injection of МnO2 
nanoparticles into a rat’s brain (in substantia nigra and tegmentum ventral area) 
in concentration equal to 87 μg/μl in 1 μl causes changes in locomotor abilities and 
spatial memory, which are related to dopaminergic neuron disorders and inflam-
mation caused by nanoparticles. МnO2 nanoparticles lead to early symptoms of 
extrapyramidal disorders with selective loss of dopaminergic neurons [27].
Histological specimens made of experimental animals’ brains were assessed; 
the assessment results allowed to detect morphologic changes in tissue structure 
depending on a dose of nanodisperse MnO2 water suspension. After a dose equal 
to 260 mg/kg of body weight a day had been introduced, the authors detected 
substantial vessels hyperemia in brain hemispheres cortex and cerebellum together 
with erythrocytes diapedesis and formation of subarachnoid hemorrhages focuses. 
There was also brain edema with perivascular and pericellular spaces dilatation 
(Figure 11). Focuses of nerve fibers demyelinization were detected as white sub-
stance fibers were unevenly painted and lighter areas with fizzy contours occurred.
After a 50 mg/kg dose focal perivascular and pericellular spaces dilatations form 
in brain cortex layers, but cortex layers still remain differentiated (Figure 12). 
Vessels in brain cortex tissues substance have thin walls, are moderately filled with 
blood, the endothelium is flattened, and there are small focal subarachnoid hemor-
rhages and focal neurons dystrophy zones. A slight perivascular spaces dilatation 
occurred after a 10 mg/kg of body weight a day (Figure 13). But when a dose was 
equal to 5 mg/kg of body weight a day, morphologic picture of brain and cerebellum 
tissues corresponded to that of control group; structure patterns were preserved in 
all the sections (Figure 14).
Figure 11. 
Brain hemispheres cortex of a rat at intragastric introduction of nanodisperse MnO2 water suspension in a 
dose equal to 260 mg/kg of body weight a day, 90th day of the experiment. There are dilated perivascular and 
pericellular spaces in brain cortex layers. Painted with hematoxylin and eosin, magnification ×400 [41].
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Figure 12. 
Brain hemispheres cortex of a rat at intragastric introduction of nanodisperse MnO2 water suspension in a 
dose equal to 50 mg/kg of body weight a day, 90th day of the experiment. There are dilated perivascular and 
pericellular spaces in brain cortex layers. Painted with hematoxylin and eosin, magnification ×400 [41].
Figure 13. 
Brain hemispheres cortex of a rat at intragastric introduction of nanodisperse MnO2 water suspension in a 
dose equal to 10 mg/kg of body weight a day, 90th day of the experiment. There is slight perivascular spaces 
dilatation in brain hemispheres cortex. painted with hematoxylin and eosin, magnification ×100 [41].
Figure 14. 
Cerebellum of a rat at intragastric introduction of nanodisperse MnO2 water suspension in a dose equal 
to 5 mg/kg of body weight a day, 90th day of the experiment. Tissue structure pattern in all cerebellum 
sections is preserved and corresponds to that of control group. Painted with hematoxylin and eosin, 
magnification ×100 [41].
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Brain cortex tissues layers are differentiated quite well. External granular layer is 
formed out of solid bunch consisting of numerous small neurons; pyramidal layer 
of brain cortex is wide and consists of polymorphous neurons. Internal granular 
layer of brain cortex and cerebellum is thin, noncontinuous, made of small pyrami-
dal and stellate cells; ganglionic layer cells in brain cortex tissues are large, poly-
morphous with dark nucleuses, diffusely located; there is a great number of diverse 
neurons (they differ in form and size) in polymorphous cells layer. Ganglionic layer 
in cerebellum tissue has one raw of Purkinje cells with well-developed eosinophilic 
granular cytoplasm and rounded dark nucleuses. Molecular layer in cerebellum 
tissue is spongy and contains a small number of minor cells. White substance in 
brain and cerebellum tissue is made of evenly painted nerve fibers bunches and 
rounded glia cells. Brain vessels have thin walls and are feebly or moderately filled 
with blood.
Comparison of pathomorphologic effects occurring at intragastric introduction 
of nanodisperse MnO2 water suspension and microdisperse MnO2 water suspension 
in a dose equal to 10 mg/kg during 90 days showed that pathomorphologic changes 
in brain and cerebellum tissues were much more apparent and wide-spread when 
nanodisperse MnO2 was introduced. After introduction of nanodisperse MnO2 
water suspension more apparent changes occurred in circulatory system in a form 
of hemodynamic disorders with focal feeble and moderate vessels hyperemia in 
brain, liver, lungs, kidneys, and heart; there were also subarachnoid hemorrhages 
in brain. Changes in lymphatic system became evident through feeble and moderate 
perivascular lymph-macrophage infiltrates in lungs tissue penetrating into adjacent 
alveoli. Pathologic changes in macrophage system were apparent through alveolar 
macrophages activation with formation of small bunches in alveoli lumen. After 
introduction of microdisperse MnO2 water suspension changes are represented by 
focal vessels hyperemia, subarachnoid hemorrhages in brain, small focal lymph-
microphage infiltrates in lungs and gastrointestinal tract. Besides, after introduc-
tion of nanodisperse MnO2 water suspension there was perivascular and pericellular 
spaces dilatation in brains, feebly apparent perivascular thin fibrous cardiosclerosis 
and feebly apparent focal protein dystrophy in hepatocytes; no such effects were 
detected after microdisperse MnO2 introduction.
All the obtained materials were summarized; it allowed to make an assumption 
on a possible mechanism of toxic impact exerted by nanodisperse MnO2 particles 
at oral introduction. Lipid peroxidation activation caused by direct damaging 
impact exerted by nanodisperse MnO2 particles on bilipid layer of cytoplasmatic 
membrane can underlie the whole process [42]. High levels of lipid hydroperoxides 
and malonic dialdehyde in blood serum are the evidence of this effect. Lower levels 
of Cu/Zn-SOD and OAS in blood serum prove antioxidation processes insuf-
ficiency. The results obtained in the research showed that astrocytes and neurons 
membranes are the first targets influenced by nanodisperse MnO2 water suspension 
at oral introduction, just as at inhalation one [21, 26]. In case of oral introduction it 
can be determined by apparent ability of nanodisperse MnO2 particles to penetrate 
into blood from gastrointestinal tract. MnO2 nanoparticles reach brain tissues com-
ing from bloodstream through capillary endothelial cells of blood brain barrier and 
accumulate in astrocytes [26]. Damaged astrocytes due to enhanced peroxidation 
of cells membranes lipids and active oxygen forms occurrence can lose their ability 
to capture and neutralize excessive quantities of “exciting” amino acid, namely 
glutamate; thus, excitotoxic effect evolves [43]. It becomes apparent as glutamate 
concentration in blood serum grows and GABA content in it decreases.
Morphological changes in brain tissues prove pathogenetic impact exerted by 
MnO2 nanoparticles which was detected in the process of biochemical parameters 
assessment. Degenerative changes evolvement can be caused by direct oxidative 
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influence which nanoparticles have on neurons, glia cells, and vessels endothelium. 
The detected effects can only result from direct contact between nanoparticles and 
brain tissues which is the evidence of probable penetration through blood-brain 
barrier. The results of examining morphologic changes in brain tissues of Wistar 
rats, which were obtained at sub-acute intragastric introduction of nanodispersed 
MnO2, enrich the existing data at sub-chronic intragastric introduction of МnO2 
nanoparticles, obtained by other authors. When МnO2 nanoparticles are once a day 
introduced into rats’ bodies orally during 28 days they are absorbed, accumulated in 
tissues after exposure and reveal their toxicity in doses lower than in case of micro-
disperse analog [44].
Some authors present data showing that chronic effects exerted by МnO2 
nanoparticles lead to its accumulation in liver tissues with their consequent damage 
[45]. Histopathologic examinations revealed that МnO2 nanoparticles had toxic 
influence on liver and kidneys [46]. There is an assumption that manganese is 
transported to organs with significant mitochondria content (to liver, pancreas and 
hypophysis in particular) where it is accumulated very fast [47].
Thus, the research revealed that nanodisperse MnO2 water suspension, when 
being introduced daily into Wistar rats via gastric tube in doses equal to 260, 50, 
10 mg/kg of body weight/a day during 90 days, causes lipid peroxidation activation 
(higher levels of lipid hydroperoxides and malonic dialdehyde in blood serum), 
and decrease in antioxidation system activity (lower OAS and Cu/Zn-SOD con-
centrations in blood serum). MnO2 nanoparticles damage neurons and astrocytes 
membranes and lead to improper neurotransmitters ratio (higher glutamate 
concentration and lower GABA in blood serum). Pathomorphologic brain disorders 
occurred, such as vessels hyperemia, subarachnoid hemorrhages, brain edema with 
perivascular and pericellular spaces dilatation, focuses of nerve fibers demyeliniza-
tion, focal dystrophic changes in vessels endothelium.
When a dose of nanodisperse MnO2 water suspension was equal to 5 mg/kg of 
body weight/a day the substance did not exert any toxic effects.
Studying chronic toxicity of nanodisperse MnO2 water suspension at 
intragastric introduction via gastric tube: toxicity of nanodisperse MnO2 water 
suspension was examined at intragastric introduction via gastric tube under chronic 
experiment conditions; the examination was accomplished in full conformity with 
Methodical guidelines on toxicological-hygienic assessment of nanomaterial safety 
and Methodical guidelines on assessment order when assessing toxic effects exerted 
by nanomaterials on laboratory animals [48, 49].
To examine chronic toxicity of nanodisperse MnO2 water suspension, a compre-
hensive experiment was performed on white male Wistar rats with body weight equal 
to 90 ± 5 g (n = 360). specific and integral parameters of negative effects in target 
organs were studied at daily intragastric introduction of nanodisperse MnO2 water sus-
pension via gastric tube. The experiment lasted for 180 days. The tested substance was 
daily introduced intragastrically via gastric tube, one time a day, the interval between 
introductions amounted to 24 hours. Mn concentration in water suspension in terms of 
MnO2 was determined it amounted to 41.37 ± 2.5 mg/cm
3. Nanodisperse MnO2 water 
suspension was introduced in the following doses: group 1–2.5 mg/kg (1/1000 LD50); 
group 2–0.25 mg/kg (1/10,000 LD50); group 3–0.05 mg/kg (1/50,000 LD50
3); group 4 
(control one)—distilled water in volume equal. The substance concentration in the 
suspension was controlled weekly. There were several assessments of animals’ overall 
health state, their survival rate, and body weight dynamics; these assessments took 
place just before the experiment beginning, then on the 30th day, 60th day, 90th day, 
120th day, 150th day, and 180th day of the experiment. Blood samples were taken from 
animals of all groups out of a caudal vein; biochemical and hematologic parameters 
were detected before the experiment beginning, on the 30th day and on the 180th 
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day. The authors selected parameters for assessing animals body responses at chronic 
introduction of the tested substance in accordance with Methodical guidelines on 
toxicological-hygienic assessment of nanomaterial safety [48]. Animals were taken 
out of the experiment on the 180th day via sparing euthanasia with carbon dioxide. 
After euthanasia they were autopsied, and microscopic assessment of morphological 
changes in internal organs followed. Nanodisperse MnO2 particles were identified in 
blood of experimental animals at intragastric introduction via gastric tube on the 180th 
day of the experiment.
The obtained results revealed that hair state, motion activity, food consump-
tion, and body weight of experimental animals in experimental groups did not have 
any discrepancies with the same parameters in the control group during the whole 
experiment. Body weight dynamics of animals from experimental groups did not 
differ authentically from body weight dynamics of animals from control group. 
There were no deaths of experimental animals in experiment and control groups at 
introduction of nanodisperse MnO2water suspension during the whole observation 
period.
Basing on the analysis of changes in hematologic and biochemical blood param-
eters of Wistar rats from groups 1 and 2 against group 4, the following negative 
effects, which characterize toxicity of nanosized MnO2 water suspension, were 
highlighted:
1. Oxidizing-antioxidant balance: lipid peroxidation activation was detected as 
per lipid hydroperoxide growth in blood serum and MDA growth in blood 
plasma. Lipid hydroperoxide concentration in blood serum of experimen-
tal animals grew on the 30th day of the experiment; it grew 2.5 times in 
group 1 and 1.6 times in group 2 in comparison with the same parameter 
in group 4. On the 180th day of the experiment, these parameters were 2.0 
and 1.7 times higher in comparison with the group 4 (р = 0.001–0.003). 
Increased MDA content was detected in experimental animals from group 1 
and 2 on the 30th day of the experiment, and it was 1.9 times higher than 
in group 4 (р = 0.001–0.002). This parameter was at the same level as 
in group 4 on the 180th day of the experiment. There was a decrease in 
antioxidation system activity. On the 30th day of the experiment, animals 
from group 1 had authentic 1.4 times lower activity of Cu/Zn-SOD than the 
same parameter in group 4. This parameter in animals from group 2 was 
1.3 times lower than in group 4. On the 180th day of the experiment, Cu/
Zn-SOD in animals from group 1 was 1.5 times lower; and in animals from 
group 2, 1.4 times lower (р = 0.001–0.005). Level of AOS in animals from 
group 1 was 4.7 times lower than in animals from group 4 on the 30th day 
of the experiment; the same parameter in group 2 was 5.9 times lower. On 
the 180th day, AOS in group 1 was 3.5 times lower; and in group 2, 4.1 times 
lower (р = 0.001–0.002). AOS and Cu/ZN-SOD parameters in group 3 cor-
responded to the same parameters in group 4 during the whole experiment.
2. Neurotransmitter balance violation: animals in group 1 had 1.4 times lower 
dopamine level in blood serum on the 30th day of the experiment; and animals 
in group 2, 1.7 times lower level than animals in group 4 (р = 0.002). On the 
180th day of the experiment, dopamine decreased 1.7 times in group 1 and 1.9 
times in group 2. By the 30th day of the experiment, there was an increase in 
glutamate level in blood serum in groups 1 and 2 in comparison with group 4; 
this parameter was 2.5 and 3.3 times higher correspondingly (р = 0.0011). 
By the 180th day of the experiment, glutamate level in group 1 was 1.9 times 
higher than in group 4 and 3.7 times higher in group 2 (р = 0.001). GABA level 
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in blood serum of animals from group 1 on the 20th day of the experiment was 
1.3 times lower; and in group 2, 1.5 times lower than in group 4; this parameter 
in groups 1 and 2 was 2.2 times lower than in group 4 on the 180th day of 
the experiment (р = 0.0011). There were not any authentic changes in these 
parameters in animals from group 3.
3. Inflammatory effect: inflammatory effect was detected in groups 1 and 2 as per 
1.6 times increase in CRP level on the 30th day of the experiment; on the 180th 
day, it was 1.9 times higher than in control group (р = 0.001–0.002). Animals 
from group 1 had higher TNF on the 30th day of the experiment (5.5 times 
higher), and animals from group 2, 6.8 times higher in comparison with the 
same parameter in group 4 (р = 0.001). On the 180th day of the experiment, 
TNF increased 4.4 times in group 1 and 5.4 times in group 2.
4. Insufficiency of bowels brush border epithelium: lower activity of β-galactosidase 
in blood serum may indicate that insufficiency of brush border epithelium in 
bowels evolves. This parameter was 3.9 times lower in group 1 and 2.9 times 
lower in group 2 in comparison with group 4 on the 180th day of the experi-
ment (р = 0.001). There were not any changes in this parameter in group 3 
against the control level.
5. Electrolyte balance violation electrolyte balance violation was detected in 
group 1 as there was an authentic decrease in K level in blood serum on the 
180th day. The level was 1.3 times lower than the same parameter level in 
group 4 (р = 0.011).
6. Sensitization: sensitization occurrence was detected as per EO increase in 
blood on the 30th day of the experiment. It grew 1.8 times in group 1 and 
1.9 times in group 2 in comparison with this parameter level in group 4 
(р = 0.013–0.026). EO-LY level increased 1.3–1.7 times and 1.3 times against 
the control parameter (р = 0.001–0.036). MO level decreased 1.6 times in 
group 1 on the 30th day; later this parameter grew 1.5 times on the 180th day 
(р = 0.006–0.023). Sensitization in animals from groups 1 and 2 remained 
on the 180th day as MO quantity increased 1.4–1.45 times, NE quantity 
decreased 1.5–1.7 times, and EO quantity decreased 3.7–5.1 times against 
group 4 (р = 0.001–0.016). There were not any authentic changes in the 
examined parameters in group 3 in comparison with control group dur-
ing the whole experiment. As the remaining biochemical parameters were 
assessed, no authentic discrepancies were revealed between experimental 
groups and control group.
No authentic changes in the examined parameters were detected against the 
control group when nanodisperse MnO2 water suspension was introduced in a 
dose equal to 0.05 mg/kg during 180 days. Electronic microscopy of animals’ 
whole blood did not reveal any nanodisperse particles in blood of animals from 
group 4. X-ray spectrometry analysis did not reveal any Mn particles either 
(Figure 15). When nanodisperse MnO2 water suspension was introduced 
intragastrically via gastric tube into Wistar rates in a dose equal to 0.25 mg/kg 
(1/10,000 LD50) during 180 days there were bunches of particles which were 
ellipsoid-shaped and needle-shaped on electronic images. There were not any 
such particles in blood of rats from the control group (Figure 16). The size of 
these particles lies within 90–130 nm range, and it can be determined by their 
agglomeration.
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In spite of the fact that X-ray spectrometry analysis did not reveal any Mn content 
in blood of experimental animals, which received a dose equal to 0.25 mg/kg (and 
it can be due to spatial resolution inaccuracy of this technique), visualized particles 
were considered to be Mn nanosized particles as they are identical with the pure 
suspension sample of the tested substance and are not detected in blood of animals 
from the control group.
Figure 16. 
X-ray spectrometry analysis of whole blood taken from an experimental animal, which received nanodisperse 
MnO2 in a dose equal to 0.25 mg/kg [50].
Figure 15. 
X-ray spectrometry analysis of whole blood taken from a male Wistar rat form the control group [50].
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4.  Examining and assessing potential reproductive and mutagenic 
toxicity of nanodisperse manganese oxide water suspension at oral 
introduction with water
Embryotoxicity means capability of a chemical to exert negative influence on 
offspring during the initial period of pregnancy, i.e., the period between concep-
tion and embryo formation. Teratogenicity means capability of a chemical to cause 
malformations and deviations in offspring postnatal development when a female 
body is exposed to this chemical during pregnancy [51].
Embryotoxic and teratogenic effects exerted by nanodisperse MnO2 were exam-
ined and assessed at oral introduction with water in accordance with methodical 
guidelines on studying embryotoxic effects of chemicals at hygienic validation of 
their maximum permissible concentration in water of water objects [52]. The exper-
iment was performed on white senior male and female Wistar rats with body weight 
equal to 200 ± 10 g (n = 90). All the animals before the experiment underwent 
14-day quarantine and were placed in standard cages made of polypropylene, two 
animals in each. Rats were divided into three groups, 15 animals in each. Groups 
1 and 2 were experimental ones, and group 3 was a control one. To get female rats 
pregnant, intact male rats and intact female rats were made to mate under con-
trol conditions during two estrous cycles. The day of sperm detection in vaginal 
smear of a female rat via microscopy was thought to be the first day of pregnancy. 
Nanodisperse MnO2 water suspension was introduced into pregnant female rats 
daily one time a day via gastric tube from the first to the twenty-first pregnancy day 
in two doses: 2.50 mg/kg (1/1000 LD50) and 0.25 mg/kg (1/10,000 LD50). Control 
group of rats received distilled water. Changes in general condition and behavior 
of experimental animals were registered during the whole experiment. Rat’s body 
weight was measured on the first, eighth, fourteenth and twenty-first day of preg-
nancy. Rats were taken out of the experiment via sparing euthanasia with carbon 
dioxide on the twenty-first day of pregnancy. Pregnant female rats were dissected 
just after euthanasia. Assessment was performed in two stages. On the first stage, 
overall disorders in fetus development (embryotoxicity) were assessed. On the 
second stage, the focus was on occurrence of congenital malformations in internal 
organs and skeletal system of fetuses (teratogenicity).
The experiment results showed that pregnant female rats from groups 1 and 2 
had ordinary motion activity during the observation period. Innate reflexes and 
reactions to external irritants were normal and rats ate their forage willingly. Their 
fur was clean, shiny, and smooth. Visible mucous tunics were physiologically colored 
without any discharge. Appearance, behavior, and body weight dynamics of rats 
from experimental groups did not have any authentic discrepancies from the same 
parameters of rats from control group during the whole observation period. There 
were not any signs of animals intoxication or death in both experimental groups 
during the whole observation period. The examination results showed that all the 
embryotoxicity parameters (number of implantation points, number of viable 
fetuses, and number of resorptions) of pregnant female rats receiving nanodisperse 
MnO2 water suspension via gastric tube formed during first to twenty-first day of 
pregnancy in doses equal to 2.5 and 0.25 mg/kg had no authentic discrepancies with 
the same parameters of rats from control group (р > 0.05). Fetuses from each litter 
did not have any visible external congenital malformations when being examined 
externally. There were not any authentic discrepancies between body weight or 
cranio-caudal body dimensions of fetuses from experimental and control groups.
There were no morphologic changes in internal organs or skeletal system of 
fetuses from groups 1 and 2 at intragastric introduction of nanodisperse MnO2 
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water suspension into Wistar rats from first to twenty-first day of pregnancy; there 
were no discrepancies between morphologic characteristics of fetuses internal 
organs and fetuses skeletal system between experimental and control groups. 
Fetuses from experimental groups and control group had multilayer flat epidermis 
with increased number of layers up to eight cells; derma cells were spindle-shaped; 
fibers were tightly located and had numerous hair follicles. Subcutaneous fatty tis-
sue was in the form of sporadic small lipocyte bunches (Figure 17). Small intestine 
wall is fully formed; limbic epithelium has characteristic appearance; Paneth cells 
are large and located not only in crypts bottom area, but also in villi epithelium. 
Beaker cells are sporadic (Figure 18).
Cartilaginous elements are mature; eosinophilic intracellular substance prevails 
in most cartilages (Figures 19 and 20).
There were numerous focuses of indirect and direct osteogenesis. Skeletal 
muscles are with small diameter of fibers and banding that is not clearly visible. 
Brain hemispheres cortex is cellular, layers are poorly differentiated and prevail 
over medulla. Cardiac histiocytes are with small section and large nucleuses. Fibers 
are spongy. Connective tissue content in cardiac muscle is minimal. Banding is not 
detected. Marrow is cellular; its bulk is represented by cells of erythropoetic type; 
there are no lipocytes.
Examining and assessing mutagenic activity of nanodisperse MnO2 water 
suspension at oral introduction with water: micronucleus test is a widespread 
technique applied for assessing mutagenic activity of new unknown chemicals; 
the test was independently worked out and implemented by Heddle and Schmid in 
early 1970s [53]. Micronucleuses are small DNA-containing formations consisting 
of acentric chromosome fragments. During telophase, these fragments can become 
a part of daughter cells nucleuses or form singular or numerous micronucleuses in 
cytoplasm. The test is based on microscopic detection of cells with micronucleuses. 
Spontaneous frequency of cells with micronucleuses amounts to 0.1–0.2% [54].
Data on mutagenic activity, which nanosized MnO2 particles, may be contradic-
tory. The authors have not been able to find any research works proving apparent 
mutagenic properties of МnO2 nanoparticles. At the same time, some experts state 
that МnO2 nanoparticles are undoubtedly genotoxic “in vivo” [55]. There are data 
given by a number of researchers that manganese nanoparticles (52.1 ± 23.8 nm) 
at 24-hour exposure on PC-12 cells in concentration equal to 10 mg/cm3 are able 
to inhibit PARK2 gene and tyrosine hydroxylase gene expression (The latter is an 
enzyme that catalyzes the first limiting stage of catecholamines synthesis, includ-
ing dopamine.) It is detected that manganese nanoparticles enhance SNCA gene 
Figure 17. 
Epidermis of Wistar rat fetus on the twenty-first day of pregnancy at intragastric introduction of nanodisperse 
MnO2 water suspension via gastric tube. Painted with hematoxylin-eosin, magnification ×200 [10].
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expression, which makes α-synucleins double in cells participating in various neu-
rodegenerating disorders evolvement. After nanodisperse, МnO2 was orally intro-
duced into Wistar rats in doses equal to 300 and 1000 mg/kg during 28 days; there 
Figure 18. 
Small intestine of a Wistar rat fetus on the twenty-first day of pregnancy at intragastric introduction of 
nanodisperse MnO2 water suspension via gastric tube. Painted with hematoxylin-eosin, magnification ×200 [10].
Figure 19. 
Brainpan and brain of a Wistar rat fetus on the twenty-first day of pregnancy at intragastric introduction of 
nanodisperse MnO2 water suspension via gastric tube. Painted with hematoxylin-eosin, magnification ×200 [10].
Figure 20. 
Ribs and intercostal muscles of a Wistar rat fetus on the twenty-first day of pregnancy at intragastric 
introduction of nanodisperse MnO2 water suspension via gastric tube. Painted with hematoxylin-eosin, 
magnification ×200 [10].
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was an increased number of DNA damages in leucocytes, and also an increased 
number of micronucleuses and chromosome aberrations in marrow cells.
Potential mutagenic activity of nanodisperse МnO2 water suspension in 
polychromatocytes (reticulocytes) of mammals marrow was assessed via micro-
nucleus test [53]. The experiment was carried out on С57В1/6 white male mice 
with body weight equal to 20.0 ± 1.0 g (n = 24). The experiment lasted for 2 days. 
Experimental animals were divided into four groups (six animals in each); groups 
1 and 2 were experimental ones, group 3 was negative control, and group 4 
was positive control. Nanodisperse МnO2 water suspension was once intro-
duced via gastric tube in two doses: group 1 received 10.3 mg/kg (1/250 LD50), 
group 2–5.15 mg/kg dose (1/500 LD50), and group 3 (negative control)—distilled 
water in a volume equal to 0.2 cm3 group 4 (positive control)—cyclophosphamide 
water suspension was once introduced intraperitoneally into mice from in a dose 
equal to 20 mg/kg in a volume equal to 0.2 cm3. Cyclophosphamide is known to be 
cytogenetically active [17].
Thus, nanodisperse MnO2 water suspension at a single intragastric introduction 
via gastric tube into С57В1/6 male mice in doses equal to 10.3 and 5.15 mg/kg does 
not cause increased micronucleuses formation in vivo and, consequently, does not 
have any mutagenic effects. As per other authors’ data, there is no information on 
possible penetration of МnO2 nanoparticles into cells nucleuses. It reduces the risk 
of direct contact between examined particles and cellular DNA [23]. DNA damage 
can occur through activation of lipid peroxidation and excessive AOF production 
from damaged membranes, which leads to cytokines induction (TNF-a tumor 
necrosis factor) and DNA damage. It can result in transcription factors activation, 
NF-KB in particular, which is responsible for polygenic expression. As a result, 
apoptotic mechanism is activated, or programmed cells death is inhibited, which 
can cause tumor activity [56, 57]. Some authors state that manganese nanoparticles 
(52.1 ± 23.8 nm) when exerting a 24-hour effect on PC-12 cells in concentration 
equal to 10 mg/cm3 are able to inhibit PARK2 gene expression and gene of tyrosine 
hydroxylase (an enzyme that catalyzes the first limiting stage of catecholamine 
synthesis, dopamine included). It is proved that manganese nanoparticles enhance 
SNCA gene expression which leads to double increase in α-synucleins in cells taking 
part in evolvement of various neurodegenerating disorders. When nanodisperse 
МnO2 was introduced into Wistar rats orally in doses equal to 300 and 1000 mg/kg 
during 28 days DNA damages in leucocytes increased, a number of micronucleuses 
and chromosome aberrations in marrow cells grew. These changes were accom-
panied with inhibition of various ATPases activity; here changes in ALAT, ASAT, 
and LDG activity in liver, kidneys, and blood serum were dose depending [44]. 
We could not find any research proving apparent mutagenic properties of МnO2 
particles. At the same time, a number of authors showed that МnO2 nanoparticles 
had evident genotoxicity “in vivo” [43].
Examining and assessing gonadotoxic activity (screening) of МnO2 oxide 
water suspension at oral introduction with water: gonadotoxicity of nano-
disperse MnO2 water suspension was examined on laboratory animals under 
subchronic experiment conditions in accordance with guidelines 2492-81 “On 
studying chemicals gonadotoxicity at hygienic standardization in water of water 
reservoirs” and international recommendations [58, 59]. The authors examined 
gonads of white male Wistar rats with body weight equal to 190 ± 20 g (n = 40). 
Experimental animals were divided into five groups, eight animals in each. Water 
suspension containing nanodisperse MnO2 was introduced in a concentration 
equal to 36.0 ± 2.3 mg/cm3, into animals from experimental groups via gastric 
tube once a day every day in following doses: group 1 received 257.7 mg/kg (1/10 
LD50), group 2–51.54 mg/kg (1/50 LD50), group 3–10.3 mg/kg (1/250 LD50), 
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group 4–5.15 mg/kg (1/500 LD50), and group 5 (control)—distilled water in a 
volume equal. The experiment lasted for 90 days. Animals euthanasia was accom-
plished with carbon dioxide. Then, a special instrument was applied to take out 
epididymis and make a longitudinal cut along it. Extraction of the epididymis in 
10 cm3 of 0.9% NaCl solution was performed during 2 minutes at room temperature 
being 22°С. Sperm quantity was calculated in Goryaev chamber. Specimens micros-
copy was performed with the use of МС 100Х microscope (Micros, Austria). The 
task was to assess such functional and morphometric parameters as sperm mass, 
total sperm quantity, number of alive sperm, sperm mobility duration, osmotic and 
acidic resistance of sperm, relative quantity of sperm pathologies.
The obtained results revealed authentic 2.18 times decrease in sperm quantity in 
male rats from group 1 against the control group (р < 0.05). Male rats from group 2 
had authentically 1.7 times lower quantity of sperm than rats from the control 
group. There were no authentic discrepancies in sperm number between male rats 
from groups 3, 4 and 5 and the control group. There was an authentic 1.2–1.3 times 
decrease in osmotic and acidic resistance of sperm in rats from groups 1 and 2 
against the control group parameter (р < 0.05). There were no discrepancies in this 
parameter in rats from groups 3, 4 and 5 and the control group. Such morphologi-
cal changes as sperm head, tail, and neck pathology occurred in groups 1 and 2 
1.7–10.3 times more frequently than in the control group (Figures 21 and 22). This 
parameter in groups 3, 4, and 5 did not have any discrepancies with the control 
group parameter.
Figure 21. 
A spermatozoon neck pathology in a male Wistar rat at oral introduction of nanodisperse МnO2 in a dose 
equal to 51.54 mg/kg, magnification ×100 [55].
Figure 22. 
A spermatozoon neck and head pathology in a male Wistar rat at oral introduction of nanodisperse МnO2 in a 
dose equal to 257.7 mg/kg, magnification ×200 [55].
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Therefore, nanodisperse МnO2 water suspension does not exert any gonadotoxic 
effects on male Wistar rats when it is introduced into them via gastric tube during 
90 days in doses equal to 10.3–5.15 mg/kg.
5. Conclusion
Contemporary research in nanotoxicology calls for studying and systemizing 
miscellaneous toxic effects exerted by new nanomaterials at various introduction 
ways and exposure period. Special attention is paid to determining target organs 
and negative effects caused by nanoparticles impacts, which do not occur after 
exposure to analog microparticles. To obtain comprehensive characteristics, one 
should study remote toxic effects such as embryotoxicity, gonadotoxicity, muta-
genic activity occurrence, etc.
The authors conducted experimental research of nanodisperse МnO2 water 
suspension at intragastric, inhalation, and skin-resorptive introduction into small 
rodents (mice and Wistar rats) with various exposure periods. It allowed to obtain a 
sufficiently profound and detailed characteristics of the toxic effects exerted by this 
substance, to determine the target organs and to reveal dose-dependent effects.
The obtained knowledge provides better understanding of toxic impact exerted 
by nanosized metal oxides, which have great potential of application in human 
activities. It is vital for working out efficient measures aimed at providing safety in 
production processes and in nanomaterials application.
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Notation and abbreviations
IT information technology
EU European Union
SUN sustainable nanotechnologies
GLP good laboratory practice
XRD X-ray diffraction
CAS chemical abstracts service
IUPAC International Union of Pure and Applied Chemistry
CTAB cetyltrimethylammonium bromide
ILAR,  Institute for Laboratory Animal Research
DELS division on earth and life studies
AOF active oxygen forms
GSSG oxidized glutathione form
GSH reduced glutathione form
CL50 concentration causing death of animals in quantity 50%
TCL0 minimal toxic concentration
LDL0 minimal lethal dose
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